文献速递产科母胎医学

双胎妊娠绒毛膜绒毛取样后胎儿丢失风险:基于倾向性评分匹配分析

Risk of fetal loss after chorionic villus sampling in twin pregnancy derived from propensity score matching analysis.
PubMed 文献 · Ultrasound Obstet Gynecol · 2022-01-13

这项多中心队列研究纳入8581例双胎妊娠,其中445例接受CVS。倾向性评分匹配258对后,CVS组与未CVS组胎儿丢失率无显著差异(11.2% vs 13.6%,OR 0.81,95%CI 0.48-1.35,P=0.415)。但CVS与背景风险存在显著交互作用(P=0.005):背景风险高时CVS后丢失风险降低(OR 0.46),背景风险低时风险升高(OR 2.45)。

要点

  • 双胎妊娠CVS后胎儿丢失风险与背景风险显著交互(P=0.005)。
  • 背景风险约6%时CVS不改变丢失风险,高于6%时风险降低,低于6%时风险升高。
  • 背景风险2.0%时,CVS后相对风险2.8,后验风险5.6%。

核心结论

  • 在双胎妊娠中,校正导致CVS和自发胎儿丢失的风险因素后,CVS似乎使胎儿丢失风险较患者背景风险增加约3.5%。

研究设计与样本

  • 多中心队列研究,纳入8581例11-13周超声检查的双胎妊娠,其中445例接受CVS。
  • 采用倾向性评分1:1匹配,比较CVS组与非CVS组至少一胎死亡的风险。

主要发现

  • CVS组任一阶段一胎或两胎死亡率为11.5%(51/445),非CVS组为6.3%(515/8136),P<0.001。
  • 倾向性评分匹配258对后,CVS组至少一胎丢失29例(11.2%),匹配非CVS组35例(13.6%),OR 0.81(95%CI 0.48-1.35),P=0.415。
  • CVS后胎儿丢失风险与背景风险存在显著交互作用(交互P=0.005):背景风险较高时CVS后丢失风险降低(OR 0.46,95%CI 0.23-0.90),背景风险较低时风险升高(OR 2.45,95%CI 0.95-7.13)。
  • 背景风险约6%时CVS不改变丢失风险;背景风险高于6%时后验风险反常降低;背景风险低于6%时后验风险指数升高。
  • 背景风险2.0%时,相对风险2.8,后验风险5.6%。

临床怎么用

  • 原文未据此给出推荐。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVE: To estimate the risk of fetal loss associated with chorionic villus sampling (CVS) in twin pregnancy, using propensity score analysis. METHODS: This was a multicenter cohort study of women with twin pregnancy undergoing ultrasound examination at 11-13 weeks' gestation, performed in eight fetal medicine units in which the leadership were trained at the Harris Birthright Research Centre for Fetal Medicine in London, UK, and in which the protocols for screening, invasive testing and pregnancy management are similar. The risk of death of at least one fetus was compared between pregnancies that had and those that did not have CVS, after propensity score matching (1:1 ratio). This procedure created two comparable groups by balancing the maternal and pregnancy characteristics that lead to CVS being performed, similar to how randomization operates in a randomized clinical trial. RESULTS: The study population of 8581 twin pregnancies included 445 that had CVS. Death of one or two fetuses at any stage during pregnancy occurred in 11.5% (51/445) of pregnancies in the CVS group and in 6.3% (515/8136) in the non-CVS group (P < 0.001). The propensity score algorithm matched 258 cases that had CVS with 258 non-CVS cases; there was at least one fetal loss in 29 (11.2%) cases in the CVS group and in 35 (13.6%) cases in the matched non-CVS group (odds ratio (OR), 0.81; 95% CI, 0.48-1.35; P = 0.415). However, there was a significant interaction between the risk of fetal loss after CVS and the background risk of fetal loss; when the background risk was higher, the risk of fetal loss after CVS decreased (OR, 0.46; 95% CI, 0.23-0.90), while, in pregnancies with a lower background risk of fetal loss, the risk of fetal loss after CVS increased (OR, 2.45; 95% CI, 0.95-7.13). The effects were statistically significantly different (P-value of the interaction = 0.005). For a pregnancy in which the background risk of fetal loss was about 6% (the same as in our non-CVS population), there was no change in the risk of fetal loss after CVS, but, when the background risk was more than 6%, the posterior risk was paradoxically reduced, and when the background risk was less than 6%, the posterior risk increased exponentially; for example, if the background risk of fetal loss was 2.0%, the relative risk was 2.8 and the posterior risk was 5.6%. CONCLUSION: In twin pregnancy, after accounting for the risk factors that lead to both CVS and spontaneous fetal loss and confining the analysis to pregnancies at lower prior risk, CVS seems to increase the risk of fetal loss by about 3.5% above the patient's background risk. © 2021 International Society of Ultrasound in Obstetrics and Gynecology.

来源:Ultrasound Obstet Gynecol,查看原文。版权归原作者所有。

引用

  1. Gil MM, Rodríguez-Fernández M, Elger T, et al. Risk of fetal loss after chorionic villus sampling in twin pregnancy derived from propensity score matching analysis. Ultrasound Obstet Gynecol. 2022. PMID: 34845786. doi:10.1002/uog.24826

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。